LITSNasdaqPharmaceutical PreparationsFiscal year ends June 30

Lite Strategy, Inc.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026

$1.16+0.01 (+0.87%)

Close on Oct 19, 2026

Margins

Share of revenue, fiscal years 2012 to 2026

–

–

–

10 fiscal years. Hover a measure to see how it is calculated.

Measure	FY2017	FY2021	FY2026
Return on equity	5.8%	-64.8%	-243.0%
Return on assets	5.2%	-21.4%	-233.4%
Current ratio	11.37	8.15	5.74
Capex to revenue	0.2%	2.0%	–
Diluted shares	2M	6M	35M

Return on equity split into margin, efficiency and leverage

Net margin27.6%

Asset turnover0.81×

Equity multiplier2.81×

Return on equity, FY202462.5%

Fiscal year	Net margin	Asset turnover	Equity multiplier	Return on equity
FY2024	27.6%	0.81×	2.81×	62.5%
FY2023	-65.6%	0.33×	3.88×	-83.1%
FY2022	-132.7%	0.23×	3.45×	-106.0%
FY2021	-117.8%	0.18×	3.03×	-64.8%
FY2020	-170.0%	0.19×	2.34×	-75.5%
FY2019	-342.2%	0.05×	1.90×	-34.2%
FY2018	-2470.3%	0.02×	1.58×	-79.1%
FY2017	11.5%	0.45×	1.11×	5.8%